Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Harvard Business School
Moodys
Fuji
Deloitte
AstraZeneca
US Army
Baxter
Dow

Generated: November 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088387

« Back to Dashboard

NDA 088387 describes SCANDONEST PLAIN, which is a drug marketed by Deproco and is included in one NDA. It is available from twelve suppliers. Additional details are available on the SCANDONEST PLAIN profile page.

The generic ingredient in SCANDONEST PLAIN is mepivacaine hydrochloride. There are six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the mepivacaine hydrochloride profile page.
Summary for 088387
Tradename:SCANDONEST PLAIN
Applicant:Deproco
Ingredient:mepivacaine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 088387
Ingredient-typeAmides
Physiological EffectLocal Anesthesia
Medical Subject Heading (MeSH) Categories for 088387
Suppliers and Packaging for NDA: 088387
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SCANDONEST PLAIN mepivacaine hydrochloride INJECTABLE;INJECTION 088387 ANDA Septodont, Inc. 0362-0753 0362-0753-05 5 BLISTER PACK in 1 CARTON (0362-0753-05) > 10 CARTRIDGE in 1 BLISTER PACK > 1.7 mL in 1 CARTRIDGE
SCANDONEST PLAIN mepivacaine hydrochloride INJECTABLE;INJECTION 088387 ANDA Septodont, Inc. 0362-1098 0362-1098-90 5 BLISTER PACK in 1 CARTON (0362-1098-90) > 10 CARTRIDGE in 1 BLISTER PACK > 1.7 mL in 1 CARTRIDGE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength3%
Approval Date:Oct 10, 1984TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
US Department of Justice
Fish and Richardson
Fuji
UBS
Argus Health
Accenture
Federal Trade Commission
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.